Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 1.502% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CN1CCN(c2nc(Nc3ccc(O)cc3)nc3ccccc23)CC1.Cl
b COc1ccccc1N1CCN(C(=O)CSc2ncnc3scc(-c4ccccc4)c23)CC1
Answer: b. COc1ccccc1N1CCN(C(=O)CSc2ncnc3scc(-c4ccccc4)c23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1N1CCN(C(=O)CSc2ncnc3scc(-c4ccccc4)c23)CC1
COc1ccccc1N1CCN(C(=O)CSc2ncnc3scc(-c4ccccc4)c23)CC1
1-[4-(2-methoxyphenyl)piperazin-1-yl]-2-(5-phenylthieno[2,3-d]pyrimidin-4-yl)sulfanylethanone